Innovation in Molecular Diagnosis Arrives in Costa Rica
We are pleased to announce that the first Vivalytic system has been installed in the laboratory of the CIMA Hospital in Costa Rica by ENHMED S.A. marking a milestone in healthcare innovation for the region. This advanced automated molecular analysis system, based on PCR technology designed by Bosch Healthcare Solutions GmbH and Randox offers a fast and accurate solution for a wide range of diagnostic tests. One of the main benefits of Vivalytic is its ability to perform sexually transmitted infection diagnostic panels. This comprehensive and highly sensitive panel allows the simultaneous detection of multiple sexually transmitted infections (STIs), facilitating a rapid and appropriate diagnosis for timely treatment.
Key benefits of Vivalytic:
- Accurate and rapid diagnosis: Reliable results in less than 60 minutes.
- Accessibility: Facilitates implementation in laboratories with high demand for diagnostic tests.
- Improved patient care: Allows for early treatment, reducing the transmission and complications associated with STIs.
- Operational efficiency: Automation that optimizes laboratory processes, improving times and reducing risks of human error. The installation of Vivalytic not only represents a technological advancement but also a commitment to public health and the well-being of Costa Ricans. We are proud to contribute to the continuous improvement of medical care in our region.